Parameters | Group A (n=15) | Group B (n=57) | P value |
---|---|---|---|
Hematological abnormality (n, %) | 13 (86.7) | 39 (68.4) | 0.280 |
WBC (×109), M (Q1-Q3) | 3.40 (1.80–5.68) | 3.90 (2.85–6.25) | 0.072 |
RBC (×1012, mean ± SD) | 3.08±0.88 | 3.59±0.64 | 0.016* |
Hb (g/L, mean ± SD) | 89.97±23.18 | 103.43±20.41 | 0.031* |
Platelet (×109, mean ± SD) | 118.80±64.68 | 160.54±82.66 | 0.074 |
Urine protein positivity (n, %) | 5 (33.3) | 27 (47.4) | 0.330 |
24hTP (g), M (Q1–Q3)a | 0.49 (0.29–1.13) | 1.40 (0.36–4.92) | 0.156 |
Scr (umol/L), M (Q1–Q3) | 62.00 (47.50–73.50) | 55.00 (47.50–73.50) | 0.856 |
GFR (ml/min/1.73m2), M (Q1–Q3) | 85.57 (77.04–109.31) | 108.76 (91.70–121.71) | 0.099 |
TP (g/L, mean ± SD) | 66.88±11.74 | 64.72±13.16 | 0.567 |
Albumin (g/L, mean ± SD) | 29.70±6.69 | 31.72±7.58 | 0.351 |
Globin (g/L, mean ± SD) | 37.18±13.39 | 33.33±9.64 | 0.310 |
Lupus nephritis (n, %) | 5 (33.3) | 28 (49.1) | 0.275 |
TC (mmol/L), M (Q1–Q3) | 3.05 (2.54–3.45) | 3.91 (3.09–4.56) | 0.030* |
TG (mmol/L), M (Q1–Q3) | 1.33 (0.75–2.02) | 1.64 (1.20–2.37) | 0.157 |
HDL (U/L), M (Q1–Q3) | 0.61 (0.42–0.69) | 0.96 (0.77–1.16) | 0.003* |
LDL (U/L), M (Q1–Q3) | 1.74 (1.11–2.34) | 2.39 (1.67–2.95) | 0.058 |
ALT (U/L), M (Q1–Q3) | 24.00 (10.00–35.00) | 23.00 (13.00–49.00) | 0.682 |
AST (U/L), M (Q1–Q3) | 29.00 (17.00–58.00) | 28.00 (18.00–56.50) | 0.950 |
LDH(U/L), M (Q1–Q3) | 262.00 (197.00–453.00) | 273.00 (206.00–614.00) | 0.767 |
EBV-IgM+ (n, %) | 0 (0/7, 0) | 2 (2/20, 10.0) | 0.975 |
EBV-IgG+ (n, %) | 7 (7/7, 100) | 20 (20/20, 100) | - |
C3 (g/L, mean ± SD) | 0.78±0.35 | 0.67±0.36 | 0.314 |
C4 (g/L, mean ± SD) | 0.16±0.12 | 0.13±0.08 | 0.401 |
ESR (mm/h), M (Q1–Q3) | 48.00 (34.50–100.25) | 41.50 (19.75–74.00) | 0.533 |
CRP (mg/L), M (Q1–Q3) | 16.31 (2.82–34.71) | 3.88 (1.50–7.17) | 0.018* |
Ferritin (ng/ml), M (Q1–Q3) b | 692.45(475.20–1248.28) | 188.85 (71.92–369.53) | 0.007* |
SLEDAI-2K, M (Q1–Q3) | 9.00 (4.00–14.00) | 12.00 (8.00–18.00) | 0.184 |
ANA (n, %) | 15 (100) | 57 (100) | - |
Anti-dsDNA antibody (n, %) | 4 (26.7) | 38 (66.7) | 0.005* |
Anti-Smith antibody (n, %) | 5 (5/11, 45.5) | 19 (19/50, 38.0) | 0.907 |
Anti-Rib P (n, %) | 4 (4/14, 28.6) | 26 (26/54, 48.1) | 0.189 |
Anti-Nuc (n, %) | 5 (5/12, 41.7) | 31 (31/55, 56.4) | 0.355 |
Anti-His (n, %) | 3 (3/13, 23.1) | 25 (25/54, 46.3) | 0.128 |
Anti-SSA/Ro52 (n, %) | 9 (9/13, 69.2) | 24 (24/52, 46.2) | 0.137 |
Anti-SSA/Ro60 (n, %) | 8 (8/12, 66.7) | 26 (26/49, 53.1) | 0.395 |
Anti-SSB (n, %) | 4 (4/12, 33.3) | 9 (9/53, 17.0) | 0.379 |
ACA (n, %) | 2 (2/8, 25.0) | 2 (2/49, 4.1) | 0.161 |
APL (n, %) | 4 (4/7, 57.1) | 15 (15/27, 55.6) | 1.000 |